|
KMID : 1140820220170020031
|
|
Urogenital Tract Infection
2022 Volume.17 No. 2 p.31 ~ p.35
|
|
|
Comprehensive Review of COVID-19 on Benign Prostate Hyperplasia Patient Symptoms
|
|
Choi Joong-Won
Suh Hong-Jin
Lee Dong-Hwan
Hwang Tae-Kon
Kim Jung-Jun
|
|
|
Abstract
|
|
|
|
Since the outbreak of the global Coronavirus disease (COVID-19) pandemic in 2019, the number of confirmed cases has increased steadily worldwide. The most common symptom of COVID-19 (SARS-CoV-2) is respiratory symptoms. On the other hand, increased voiding frequency and lower urinary tract symptoms (LUTS) have also been reported. Regarding the relationship between LUTS and COVID-19, only small size (n<100) retrospective studies have been reported, but the post-International Prostate Symptom Score (IPSS) increases compared to pre-IPSS after a COVID-19 infection in those older than 50 years. α-blockers and phosphodiesterase-5 inhibitors are relatively safe, but there are conflicting reports on 5α-reductase inhibitors; hence, further research is needed. Four major theories have been argued regarding the relationship between LUTS and COVID-19: renin-angiotensin system-related, androgen-related, inflammation-related, and metabolic derangement-related. In conclusion, elderly male patients often have benign prostate hyperplasia as a co-morbidity, and the severity of COVID-19 is high in this group. Therefore, voiding symptoms in these patient groups is of particular concern.
|
|
|
KEYWORD
|
|
|
COVID-19, SARS-CoV-2, Lower urinary tract symptoms, Prostatic hyperplasia
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|
|